Rises and Falls in Donor-Specific and Third-Party HLA Antibody Levels After Antibody Incompatible Transplantation
Authors:
- Rob HigginsRob Higgins
- David LoweDLDavid Lowe
- Mark HathawayMHMark Hathaway
- For LamFLFor Lam
- Habib KashiHKHabib Kashi
- Lam Chin TanLTLam Chin Tan
- Chris ImrayCIChris Imray
- Simon FletcherSFSimon Fletcher
- Klaus ChenKCKlaus Chen
- Nithya KrishnanNKNithya Krishnan
- Rizwan HamerRHRizwan Hamer
- Daniel ZehnderDZDaniel Zehnder
- 27 March 2009
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 87 (6) , 882-888
Abstract
After human leukocyte antigen (HLA) antibody-incompatible transplantation, donor specific and third party HLA antibodies may be found, and their levels fall in a donor-specific manner during the first month. However, these changes have not been previously described in detail. Donor-specific HLA antibody (DSA) and third-party HLA antibody (TPA) levels were measured using the microbead method in 44 presensitized patients who had renal transplantation. DSA+TPA fell in the first 4 days after transplantation, and greater falls in DSA indicated absorption by the graft. This occurred for class I (57.8% fall compared with 20.2% for TPA, P<0.0005), HLA DR (63.0% vs. 24.3%, P<0.0004), and for HLA DP/DQ/DRB3-4 (34% vs. 17.5%, P=0.014). Peak DSA levels occurred at a mean of 13 days posttransplant, and they were higher than pretreatment in 25 (57%) patients and lower in 19 (43%) patients (P=ns). The risk of rejection was associated with peak DSA levels; 15 of 25 (60%) patients with DSA at median fluorescence intensity (MFI) more than 7000U experienced rejection, compared with 4 of 7 (57%) patients with peak DSA MFI 2000 to 7000U, and 2 of 12 (17%) patients with peak DSA MFI less than 2000U (P<0.02). DSA levels subsequently fell in a donor specific manner compared to TPA. DSA levels may change markedly in the first month after antibody incompatible transplantation, and the risk of rejection was associated with higher pretreatment and peak levels.Keywords
This publication has 18 references indexed in Scilit:
- Blood Levels of Donor-Specific Human Leukocyte Antigen Antibodies After Renal Transplantation: Resolution of Rejection in the Presence of Circulating Donor-Specific AntibodyTransplantation, 2007
- Posttransplant Prophylactic Intravenous Immunoglobulin in Kidney Transplant Patients at High Immunological Risk: A Pilot StudyAmerican Journal of Transplantation, 2007
- Kidney Transplantation in Patients with Antibodies against Donor HLA Class IIAmerican Journal of Transplantation, 2007
- Extremely High Association Between Appearance of HLA Antibodies and Failure of Kidney Grafts in a Five-Year Longitudinal StudyAmerican Journal of Transplantation, 2007
- Factors Associated With and Predictive of Persistence of Donor-Specific Antibody After Treatment With Plasmapheresis and Intravenous ImmunoglobulinHuman Immunology, 2005
- Specific and durable elimination of antibody to donor HLA antigens in renal-transplant patientsTransplantation, 2003
- Posttransplantation production of donor HLA-specific antibodies as a predictor of renal transplant outcome1Transplantation, 2003
- THE SIGNIFICANCE OF THE ANTI-CLASS I ANTIBODY RESPONSETransplantation, 1990
- PRECISE SPECIFICITY OF INDUCED TUBULAR HLA-CLASS II ANTIGENS IN RENAL ALLOGRAFTSTransplantation, 1987
- Effect of Antiidiotypic Antibodies to HLA on Graft Survival in Renal-Allograft RecipientsNew England Journal of Medicine, 1987